KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Asset Writedowns and Impairment (2018 - 2021)

Cme (CME) has disclosed Asset Writedowns and Impairment for 6 consecutive years, with -$500000.0 as the latest value for Q2 2021.

  • On a quarterly basis, Asset Writedowns and Impairment fell 110.42% to -$500000.0 in Q2 2021 year-over-year; TTM through Sep 2021 was -$1.1 million, a 104.01% decrease, with the full-year FY2020 number at $26.3 million, down 56.96% from a year prior.
  • Asset Writedowns and Impairment was -$500000.0 for Q2 2021 at Cme, down from $500000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $39.5 million in Q3 2019 to a low of -$9.5 million in Q4 2018.
  • A 4-year average of $8.7 million and a median of $2.6 million in 2020 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: soared 315.79% in 2019, then tumbled 110.42% in 2021.
  • Cme's Asset Writedowns and Impairment stood at -$9.5 million in 2018, then soared by 515.79% to $39.5 million in 2019, then tumbled by 102.78% to -$1.1 million in 2020, then surged by 54.55% to -$500000.0 in 2021.
  • Per Business Quant, the three most recent readings for CME's Asset Writedowns and Impairment are -$500000.0 (Q2 2021), $500000.0 (Q1 2021), and -$1.1 million (Q4 2020).